LONDON--(BUSINESS WIRE)--According to the latest market study released by Technavio, the global circulatory support devices market is expected to grow at a CAGR of more than 11% during the forecast period.
This research report titled ‘Global Circulatory Support Devices Market 2017-2021’ provides an in-depth analysis of the market in terms of revenue and emerging market trends. This report also includes an up to date analysis and forecasts for various market segments and all geographical regions.
This report is available at a USD 1,000 discount for a limited time only: View market snapshot before purchasing
Buy 1 Technavio report and get the second for 50% off. Buy 2 Technavio reports and get the third for free.
The market research analysis categorizes the global circulatory support devices market into three major product segments:
- Ventricular assisted device (VAD)
- Extracorporeal membrane oxygenation (ECMO)
- Total artificial heart (TAH)
Looking for more information on this market? Request a free sample report
Technavio’s sample reports are free of charge and contain multiple sections of the report including the market size and forecast, drivers, challenges, trends, and more.
Global VAD market
The global VAD market is growing at a significant rate owing to its cost-effectiveness when compared to heart transplantation. Shortage of donors and improved survival rate are the major factors driving the demand for these supporting devices. VAD will provide aid to the heart but not completely replace heart activities. Also, the advances in technology in terms of design are playing a key role in higher adoption of VAD in developed countries. The growing number of patients with congestive heart failure (IV stage) is another main factor driving the sales of VADs in the global circulatory support devices market. Moreover, advances in technology have led to the development of new generation LVADs, which are small, less noisy, and durable with enhanced power sources.
Global ECMO market
The global ECMO market is expected to grow at a moderate rate owing to the growing incidence of cardiovascular disorders, respiratory disorders, and the growing geriatric population. In addition, the outspread application of ECMO is driving the demand through various application segments such as cardiac, respiratory, and extracorporeal cardiopulmonary resuscitation (ECPR).
“In addition, a significant rise in ECMO centers, rising awareness through conferences and training programs, and the advances in technology are significant factors driving the demand for ECMO supporting devices during the forecast period. Also, the growing older population in APAC and a significant number of people with cardiopulmonary diseases in developing nations such as China and India are expected to provide the potential growth opportunity for ECMO devices,” says Barath Palada, a lead analyst at Technavio for cardiovascular devices research.
Global TAH market
The global TAH market is growing at a faster rate compared with other circulatory assist devices globally. Europe is the leading revenue contributor to the global TAH market, followed by the Americas and APAC. Europe dominates the market, as the device got European Medicines Agency (EMA) approval before the US FDA approval and had early adoption advantage for the end-users.
The market for TAH is expected to benefit from the fact that it is the only option, which can provide a permanent solution in the absence of a donor's heart. The TAH is gaining popularity among critically ill patients, who are in life-threatening condition due to extreme malfunction of their heart. The TAH will enhance the life expectancy of people with end-stage heart failure and extend the life expectancy over months compared with the other circulatory support devices.
The top vendors highlighted by Technavio’s market research analysts in this report are:
- Medtronic
- St. Jude Medical
- ABIOMED
- ReliantHeart
- Berlin Heart
Browse Related Reports:
- Global Percutaneous Coronary Intervention (PCI) Devices Market 2017-2021
- Global Carotid Stents Market 2017-2021
- Global Cardiac Rhythm Management (CRM) Devices Market 2017-2021
About Technavio
Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.
With over 500 specialized analysts, Technavio’s report library consists of more than 10,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
If you are interested in more information, please contact our media team at media@technavio.com.
